Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The paradigm of drug resistance in cancer: an epigenetic perspective. | Biosci Rep | 2022 | 35438143 | PubTator, text mining | PubMed |
| Sintilimab for the treatment of non-small cell lung cancer. | Biomark Res | 2022 | 35436956 | PubTator, text mining | PubMed |
| Can Gene Expression Analysis in Zero-Time Biopsies Predict Kidney Transplant Rejection? | Front Med (Lausanne) | 2022 | 35433772 | PubTator, text mining | PubMed |
| Chromatin-Remodeling Factor BRG1 Is a Negative Modulator of L. donovani in IFNγ Stimulated and Infected THP-1 Cells. | Front Cell Infect Microbiol | 2022 | 35433496 | PubTator, text mining | PubMed |
| Precision medicine in sepsis and septic shock: From omics to clinical tools. | World J Crit Care Med | 2022 | 35433311 | PubTator, text mining | PubMed |
| Prognosis and Characterization of Immune Microenvironment in Head and Neck Squamous Cell Carcinoma through a Pyroptosis-Related Signature. | J Oncol | 2022 | 35432539 | PubTator, text mining | PubMed |
| Current Topics of Relevance to the Xenotransplantation of Free Pig Islets. | Front Immunol | 2022 | 35432379 | PubTator, text mining | PubMed |
| Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients. | Front Oncol | 2022 | 35425715 | PubTator, text mining | PubMed |
| Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials. | Front Pharmacol | 2022 | 35422702 | PubTator, text mining | PubMed |
| Editorial: Negative Regulators of Innate Immunity and Their Role in Host Responses to Injury and Infection. | Front Immunol | 2022 | 35418994 | PubTator, text mining | PubMed |
| Luteolin Causes 5'CpG Demethylation of the Promoters of TSGs and Modulates the Aberrant Histone Modifications, Restoring the Expression of TSGs in Human Cancer Cells. | Int J Mol Sci | 2022 | 35409426 | PubTator, text mining | PubMed |
| Emerging Insights into the Impact of Air Pollution on Immune-Mediated Asthma Pathogenesis. | Curr Allergy Asthma Rep | 2022 | 35394608 | PubTator, text mining | PubMed |
| Pre-treatment serum albumin and mutational burden as biomarkers of response to immune checkpoint blockade. | NPJ Precis Oncol | 2022 | 35393553 | PubTator, text mining | PubMed |
| Microvascular Inflammation of the Renal Allograft: A Reappraisal of the Underlying Mechanisms. | Front Immunol | 2022 | 35392097 | PubTator, text mining | PubMed |
| Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery. | Nat Commun | 2022 | 35388006 | PubTator, text mining | PubMed |
| BiTSC 2: Bayesian inference of tumor clonal tree by joint analysis of single-cell SNV and CNA data. | Brief Bioinform | 2022 | 35368055 | PubTator, text mining | PubMed |
| Novel insights into NOD-like receptors in renal diseases. | Acta Pharmacol Sin | 2022 | 35365780 | PubTator, text mining | PubMed |
| ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma. | Front Genet | 2022 | 35360875 | PubTator, text mining | PubMed |
Single Time Frame Overview of the Genetic Changes in Conjunctival Melanoma from Intraepithelial Disease to Invasive Melanoma: A Study of 4 Exenteration Specimens Illustrating the Potential Role of Cyclin D1. | Ocul Oncol Pathol | 2022 | 35356600 | PubTator, text mining | PubMed |
| Response of Human Liver Tissue to Innate Immune Stimuli. | Front Immunol | 2022 | 35355993 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=42